(Press-News.org) HOUSTON ― Lauren Averett Byers, M.D., professor of Thoracic/Head & Neck Medical Oncology at The University of Texas MD Anderson Cancer Center, has received the
2025 Edith and Peter O’Donnell Award in Medicine from the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST). The award recognizes her fundamental discoveries and contributions to identifying novel therapeutic strategies for small cell lung cancer (SCLC), which have paved the way for personalized treatments, even in the most highly recalcitrant cancers.
The O’Donnell Awards support exceptional Texas researchers addressing the essential roles that science and technology play in society, and demonstrating the highest standards of professional performance, creativity and resourcefulness. The recognition is given annually in five categories. Byers will be honored during the TAMEST Annual Conference and 2025 O’Donnell Awards ceremony in February in Houston.
“Receiving the O’Donnell Award is a distinct honor, and I am hopeful this recognition will propel further research in small cell lung cancer,” Byers said. “I’m especially grateful to my team of exceptional scientists and clinicians, who have worked together to translate our research findings to address unmet needs by providing new, more personalized treatment options for our patients.”
Internationally recognized as a SCLC expert, Byers led a team of researchers to develop the first comprehensive framework to classify the disease into four unique subtypes based on gene expression. In a study published in Cancer Cell, her team also identified potential therapeutic targets for each SCLC subtype. This approach to subtyping SCLC resulted in subsequent seminal publications that identify which patients are most likely to benefit from immunotherapy.
“Dr. Byers is an established leader in the field and a uniquely gifted scientist and physician. She is poised to continue to make important contributions to lung cancer research and the treatment of cancer, broadly,” said Giulio Draetta, M.D., Ph.D., chief scientific officer at MD Anderson. “This recognition underscores her commitment to rigorous, exemplary science – an essential hallmark of our efforts to advance research and develop powerful new treatments for our patients.”
As a physician-scientist, Byers focuses her research on high-throughput molecular profiling to identify new therapeutic targets, predictive biomarkers and mechanisms of resistance in SCLC. She has rapidly advanced these findings into clinical trials and leads a multidisciplinary translational research team that leverages tumors and liquid biopsies from patients with lung cancer to accelerate the development of personalized treatments and biomarkers.
Byers has led a number of clinical trials exploring innovative new treatments, including the first chimeric antigen receptor (CAR) T cell therapy for patients with SCLC. Her contributions in SCLC have been recognized in a National Cancer Institute report to the U.S. Congress as among the most impactful advances in the past decade.
“Dr. Byers is an outstanding medical oncologist and translational scientist, and we have already seen her work change standards of care for patients with small cell lung cancer,” said nominator James P. Allison, Ph.D., regental professor and chair of Immunology and director of the James P. Allison Institute at MD Anderson. “We celebrate her contributions to the field of cancer research, as she excels in both translating fundamental research findings and in mentoring the next generation of research leaders.”
Byers earned her B.A. in molecular biology from Princeton University in 1998 and her M.D. from Baylor College of Medicine in 2003. She also earned a M.S. in patient-based research from The University of Texas Graduate School of Biomedical Sciences in 2009.
As a medical student, Byers was selected for the prestigious Howard Hughes Medical Institute (HHMI)-National Institutes of Health (NIH) Research Scholars (Cloister) Program, joining the lab of Louis Staudt, M.D., Ph.D., at the National Cancer Institute (NCI). There, Byers was part of a team pioneering early gene expression profiling, leading to the discovery of molecularly distinct cancer subtypes.
She joined MD Anderson in 2006 as a clinical fellow and later became an advanced scholar fellow. Since then, Byers’ contributions to the field have earned numerous awards from peers, funding institutions and scientific journals. She co-leads several translational and clinical lung cancer research programs at MD Anderson and is co-principal investigator of the NIH/NCI SCLC Consortium Coordinating Center. Byers is an active mentor for undergraduates, graduate students, post-doctoral fellows and clinical fellows. Her mentees have earned recognition with awards and grants and have advanced to faculty positions at leading institutions, including MD Anderson.
Watch the TAMEST award video on Byers’ pioneering research here. Read this press release in the MD Anderson Newsroom.
- 30 -
END
To fill this knowledge gap, a group of researchers led by Professor Kangseok Lee, from the Department of Life Science, Chung-Ang University set out to explore the biogenesis and function of specific tRFs like tRHs. Their study published in Volume 15 of Nature Communications on 28 October 2024, opens exciting avenues for the future of cancer therapies and introduces potential biomarkers for improved clinical outcomes.
This study was inspired by a serendipitous discovery in 2010, when the researchers found high levels of small RNA fragments derived from specific tRNAs, rather than the anticipated ...
The secret of the female orgasm may have been revealed by scientists in a pioneering study.
Researchers led by the University of Essex found that women climax more frequently if they have high levels of an inward-looking sense known as interoception.
Dr Megan Klabunde, from the Department of Psychology, discovered women who noticed and attend to internal bodily signals– like heartbeats, breathing, and sensual touch sensations - have more frequent orgasms.
Dr Klabunde says this is one of the first times healthy female orgasms have been studied and they are important for women’s well-being and boost relationship satisfaction.
Improving lives
It is hoped the ...
CLEVELAND—Rechargeable lithium-ion batteries power everything from electric vehicles to wearable devices. But new research from Case Western Reserve University suggests that a more sustainable and cost-effective alternative may lie in zinc-based batteries.
In a study published recently in Angewandte Chemie, researchers announced a significant step toward creating high-performance, low-cost zinc-sulfur batteries.
“This research marks a major step forward in the development of safer and more ...
Trillions of bacteria work in the chemical and pharmaceutical industries, helping produce everything from beer and facial creams to biodiesel and fertilizer. The pharmaceutical industry, in particular, relies heavily on bacteria for producing substances like insulin and penicillin.
Harnessing bacteria's industrial contributions have revolutionized global health, but their work comes at a high energy cost. Additionally, solvents and continuous production of new bacteria are often necessary, as they don't last long in their jobs.
Changzhu ...
Large-scale protein and gene profiling have massively expanded the landscape of cancer-associated proteins and gene mutations, but it has been difficult to discern whether they play an active role in the disease or are innocent bystanders. In a study published in Nature Cancer, researchers at Baylor College of Medicine revealed a powerful and unbiased machine learning-based approach called FunMap for assessing the role of cancer-associated mutations and understudied proteins, with broad implications for advancing cancer biology and informing therapeutic strategies.
“Gaining functional information on the genes and proteins associated with cancer is an important ...
Cleveland Clinic researchers have found definitive proof of a kidney microbiome that influences renal health and kidney stone formation, demonstrating that the urinary tract is not sterile and low levels of bacteria are normal.
The Nature Communications publication describes the rigorous multi-pronged approach a team led by Aaron Miller, PhD, and José Agudelo, MD, used to identify and characterize the small bacterial community by combining preclinical, human and dish studies.
They also identified certain bacteria within the microbiome ...
IMDEA Software Institute researchers Diego Castejón Molina, Dimitris Vasilopoulos and Pedro Moreno-Sanchez present a system that represents a step forward in digital purchases. Their research is reflected in the study: “MixBuy: Contingent Payment in the Presence of Coin Mixers” which has been accepted at the Privacy Enhancing Technologies Symposium (PETS).
Context
Today, many products can be purchased with cryptocurrencies such as Bitcoin: video games, books or cell phone plans. In some countries, such as El Salvador, you can even buy ...
Having a quality breakfast that provides the right amount of energy to face the day, around a quarter of daily intake, reduces the risk of cardiovascular disease. This is highlighted by a study conducted by the Hospital del Mar Research Institute and published in the Journal of Nutrition, Health and Aging. The study followed the progress of 383 participants in the PREDIMED-Plus project, a randomized clinical trial comparing the effects of a Mediterranean diet combined with physical activity versus dietary recommendations alone on cardiovascular disease. No previous study had analyzed the impact of energy intake and the nutritional ...
A new study assessing provincial and territorial variations in reimbursement criteria of drug coverage for patients covered by Canada's public pharmacare programs for two common cardiovascular conditions revealed significant inequities and deficiencies in access to medications and treatment. The article appearing in the Canadian Journal of Cardiology, published by Elsevier, exposes the complexities of the Canadian drug review process and makes a case for a unified framework to improve the present infrastructure, moving towards ensuring the best care for patients with cardiovascular disease.
Canada has been praised for its universal healthcare system and low ...
To commercialize a completely new way of creating colors, a coalition between Kobe University and the venture capital firm ANRI received startup development funding of ¥300 million from the Japan Science and Technology Agency (JST). With their lightweight, unfading and environmentally friendly way of producing color, they want to first enter the security ink and cosmetics markets before moving om to paints for cars, airplanes and other mobility applications.
We color our world, and ourselves, to display information, to protect the underlying surface, to uniquely identify an object, ...
